Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1321473

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1321473

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Monoclonal Antibodies In Veterinary Health Market Growth & Trends

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights

  • Based on animal type, the dog segment held the dominant revenue share in 2022 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 50% in 2022, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2022, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 40% in 2022, owing to the presence of major market players in the region
Product Code: GVR-4-68039-973-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End-User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. SWOT Analysis
    • 7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participation Categorization
  • 8.2. Key Company Profiles
    • 8.2.1 Zoetis
    • 8.2.2 Merck & Co, Inc.
    • 8.2.3 Elanco
    • 8.2.4 Boehringer Ingelheim GmbH
    • 8.2.5 Indian Immunologicals Ltd
    • 8.2.6 Virbac
      • 8.2.6.1. Participant's Overview
      • 8.2.6.2. Product Benchmarking
      • 8.2.6.3. Financial Performance
      • 8.2.6.4. Strategy Mapping
  • 8.3. List of Other Players (inclusive of companies with pipeline products)
Product Code: GVR-4-68039-973-5

List of Tables

  • Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Region, 2018 - 2030 (USD Million)
  • Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 4 North America Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 5 North America Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 6 US Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 7 US Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 8 US Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 9 Canada Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 10 Canada Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 11 Canada Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 13 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 14 Europe Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 15 Europe Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 16 Germany Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 17 Germany Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 18 Germany Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 19 UK Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 22 Spain Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 23 Spain Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 24 Spain Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 25 Italy Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 26 Italy Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 27 Italy Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 29 France Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 30 France Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 33 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 34 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 35 Japan Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 36 Japan Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 37 Japan Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 38 China Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 39 China Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 40 China Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 41 India Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 42 India Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 43 India Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 44 Australia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 45 Australia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 46 Australia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 47 South Korea Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 48 South Korea Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 49 South Korea Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 51 LATAM Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 52 LATAM Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 53 LATAM Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 54 Brazil Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 55 Brazil Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 56 Brazil Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 57 Mexico Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 58 Mexico Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 59 Mexico Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 60 Argentina Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 61 Argentina Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 62 Argentina Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 64 MEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 65 MEA Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 66 MEA Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 67 South Africa Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 68 South Africa Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 69 South Africa Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 70 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 71 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 72 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 73 Participant's overview
  • Table 74 Financial performance
  • Table 75 Product Benchmarking
  • Table 76 Key companies undergoing strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Ansoff's matrix analysis
  • Fig. 14 Heat map analysis
  • Fig. 15 Market penetration vs growth prospect mapping
  • Fig. 16 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
  • Fig. 17 Strategy mapping
  • Fig. 18 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2022
  • Fig. 19 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
  • Fig. 20 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Monoclonal Antibodies in Veterinary Health Market application outlook: 2022
  • Fig. 23 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
  • Fig. 24 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 25 Pain market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2022
  • Fig. 28 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
  • Fig. 29 Veterinary Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace: 2022
  • Fig. 32 Regional outlook, 2018 & 2030
  • Fig. 33 North America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participant categorization
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!